Takeda Pharmaceutical Co Ltd
TAK
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 20-F |
6/25/2025 |
Q4 |
2025 |
3/31/2025 |
SEC |
view |
|
| 20-F |
6/26/2024 |
Q4 |
2024 |
3/31/2024 |
SEC |
view |
|
| 20-F |
6/28/2023 |
Q4 |
2023 |
3/31/2023 |
SEC |
view |
|
| 20-F |
6/29/2022 |
Q4 |
2022 |
3/31/2022 |
SEC |
view |
|
| 20-F |
6/29/2021 |
Q4 |
2021 |
3/31/2021 |
SEC |
view |
|
| WIREPR |
5/11/2021 |
Q4 |
2021 |
3/31/2021 |
WIRE |
view |
data |
| 20-F |
6/24/2020 |
Q4 |
2020 |
3/31/2020 |
SEC |
view |
|
| WIREPR |
5/13/2020 |
Q4 |
2020 |
3/31/2020 |
WIRE |
view |
data |
| WIREPR |
10/31/2019 |
Q2 |
2020 |
9/30/2019 |
WIRE |
view |
data |
| WIREPR |
7/31/2019 |
Q1 |
2020 |
6/30/2019 |
WIRE |
view |
data |
| 20-F |
6/27/2019 |
Q4 |
2019 |
3/31/2019 |
SEC |
view |
|